Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

Overexpression of Mitofusin 2 Inhibited Oxidized Low-Density Lipoprotein Induced Vascular Smooth Muscle Cell Proliferation and Reduced Atherosclerotic Lesion Formation in Rabbit.

Mitofusin 2 Decreases Intracellular Lipids in Macrophages by Regulating Peroxisome Proliferator-Activated Receptor-Γ.

Mitofusin 2 Triggers Vascular Smooth Muscle Cell Apoptosis Via Mitochondrial Death Pathway

Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.

Abstract 298: Flavin Containing Monooxygenase 2 in Cardiac Fibrosis

Effect of Mitofusin 2 Gene with Protein Kinase A Phosphorylation Site Deletion on the Proliferation of Vascular Smooth Muscle Cells

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.

Induction of MIF expression by oxidized LDL via activation of NF-κB in vascular smooth muscle cells

Mfn2 Inhibits Chronic Rejection of the Rat Abdominal Aorta by Regulating TGF-β1 Levels.

Effect of Mitofusin 2 Gene Mutations on the Proliferation of Vascular Smooth Muscle Cells

Inhibition of Mitofusin-2 Promotes Cardiac Fibroblast Activation via the PERK/ATF4 Pathway and Reactive Oxygen Species

Effect of removal of PKA phosphorylation site from Mfn2 gene on the proliferation of VSMC

Mfn2 Overexpression Attenuates Cardio-Cerebrovascular Ischemia–Reperfusion Injury Through Mitochondrial Fusion and Activation of the AMPK/Sirt3 Signaling

Adiponectin Affects Vascular Smooth Muscle Cell Proliferation and Apoptosis Through Modulation of the Mitofusin-2-mediated Ras-Raf-Erk1/2 Signaling Pathway.

Early Protective Effect of Mitofusion 2 Overexpression in STZ-induced Diabetic Rat Kidney

The Effects of Myocyte Enhancer Factor 2A Gene on the Proliferation, Migration and Phenotype of Vascular Smooth Muscle Cells.

Abstract 3288: Mitofusin 2 Inhibits Cardiac Fibroblast Proliferation and Collagen Synthesis Stimulated by Angiotensin II in Rat

De Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in Rabbits.

M2 Macrophage-Derived Exosomes Inhibit Atherosclerosis Progression by Regulating the Proliferation, Migration, and Phenotypic Transformation of Smooth Muscle Cells

Mitofusin 2 Participates in Mitophagy and Mitochondrial Fusion Against Angiotensin II-Induced Cardiomyocyte Injury

Mef2c Protects Against The Development Of Atherosclerosis Via Inhibiting Tlr/Nf-Kappa B Activation